TLIS logo

Talis Biomedical Corporation (TLIS)

Profile

Full Name

Talis Biomedical Corporation

Ticker

NASDAQ: TLIS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 12, 2021

Indexes

Not included

Website

https://talisbio.com

Employees

99

Key Details

Price

$1.50(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$412.00K(-88.72% YoY)

Annual EPS

$0.00(0.00% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.50
    TLIS price is $1.50

    30-Day Relative Volume

    1.07
    TLIS 30-day relative volume is 1.07

    Price Performance

    Price Most recent change

    0%
    TLIS price has remained unchanged on Aug 18, 2025

    Price YTD change

    -14.72%
    TLIS price is down -14.72% since January 1st

    Price 1-year change

    -65.99%
    TLIS price is down -65.99% year-on-year

    Price 3-year change

    -89.08%
    TLIS price is down -89.08% over the past 3 years

    Price Range

    Price All-time high

    $508.50
    TLIS price is currently -99.71% below its historical high of $508.50

    Price 3-year low

    $1.04
    TLIS price is currently +44.23% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.73M
    TLIS market capitalization is $2.73 million

    Market cap 3-year change

    -88.79%
    TLIS market capitalization is down -88.79% over the past 3 years

    Market cap All-time high

    $712.74M
    TLIS market capitalization is currently -99.62% below its historical high of $712.74 million

    Market cap sector rank

    6.05%
    TLIS market capitalization is higher than 6.05% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    TLIS shares outstanding has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    +2.72%
    TLIS shares outstanding is up +2.72% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.37
    TLIS beta is 0.37

    200-day SMA

    $1.60
    TLIS price is currently -6.48% below its 200-day simple moving average

    50-day SMA

    $1.43
    TLIS price is currently +4.91% above its 50-day simple moving average

    RSI

    65.25
    TLIS 14-day relative strength index is 65.25

    Volume

    1.07
    TLIS 30-day relative volume is 1.07

    ATR

    $0.01
    TLIS average true range is $0.01

    10-day Historical Volatility

    0.00%
    TLIS 10-day historical volatility is 0.00%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $412.00K
    TLIS annual revenue is $412.00 thousand

    Revenue Analysts estimate

    -
    TLIS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -88.72%
    TLIS annual revenue is down -88.72% year-on-year

    Revenue Sector rank

    33.86%
    TLIS annual revenue is higher than 33.86% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    TLIS annual earnings per share is $0.00

    EPS Analysts estimate

    -$23.32
    TLIS annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    0%
    TLIS annual earnings per share has remained unchanged year-on-year

    EPS Sector rank

    82.56%
    TLIS annual earnings per share is higher than 82.56% of companies in Healthcare sector

    Profit

    Gross profit

    $371.00K
    TLIS annual gross profit is $371.00 thousand

    Gross margin

    -96.84%
    TLIS annual gross profit margin is -96.84%

    Operating profit

    -$66.81M
    TLIS annual operating income is -$66.81 million

    Operating margin

    -15.96K%
    TLIS annual operating profit margin is -15.96 thousand%

    Net income

    -$62.01M
    TLIS annual net profit is -$62.01 million

    Net margin

    -15.05K%
    TLIS annual net profit margin is -15.05 thousand%

    Expenses

    Total expenses

    $67.23M
    TLIS annual total expenses is $67.23 million

    Operating expenses

    $67.19M
    TLIS annual total operating expenses is $67.19 million

    Cost of goods sold

    $811.00K
    TLIS annual cost of goods sold is $811.00 thousand

    Selling, general & administrative expenses

    $28.21M
    TLIS annual SGA is $28.21 million

    Depreciation and amortization

    $770.00K
    TLIS annual depreciation & amortization is $770.00 thousand

    Interest expense

    $0.00
    TLIS annual interest expense is $0.00

    Income tax

    $0.00
    TLIS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$66.81M
    TLIS annual earnings before interest & taxes is -$66.81 million

    EBITDA

    -$66.05M
    TLIS annual EBITDA is -$66.05 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $98.34M
    TLIS annual total assets is $98.34 million

    Non current assets

    $20.66M
    TLIS annual long term assets is $20.66 million

    Current assets

    $77.68M
    TLIS annual total current assets is $77.68 million

    Cash and cash equivalents

    $76.73M
    TLIS annual cash & cash equivalents is $76.73 million

    Accounts receivable

    $50.00K
    TLIS annual accounts receivable is $50.00 thousand

    Inventory

    $0.00
    TLIS annual inventory is $0.00

    Liabilities

    Total liabilities

    $29.22M
    TLIS annual total liabilities is $29.22 million

    Long term liabilities

    $20.45M
    TLIS annual total long term liabilities is $20.45 million

    Current liabilities

    $8.77M
    TLIS annual total current liabilities is $8.77 million

    Accounts payable

    $1.34M
    TLIS annual accounts payable is $1.34 million

    Debt

    Total debt

    $19.67M
    TLIS annual total debt is $19.67 million

    Total debt 1-year change

    -41.43%
    TLIS annual total debt is down -41.43% year-on-year

    Long term debt

    $16.79M
    TLIS annual long term debt is $16.79 million

    Short term debt

    $2.88M
    TLIS annual short term debt is $2.88 million

    Equity & Capital

    Shareholders equity

    $69.12M
    TLIS annual stockholders equity is $69.12 million

    Book value

    $69.11M
    TLIS annual book value is $69.11 million

    Retained earnings

    -$539.96M
    TLIS annual retained earnings is -$539.96 million

    Working capital

    $68.91M
    TLIS annual working capital is $68.91 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$53.24M
    TLIS annual cash flow from operations is -$53.24 million

    Cash from operations 1-year change

    +46.83%
    TLIS annual cash flow from operations is up +46.83% year-on-year

    Cash from investing

    -$486.00K
    TLIS annual cash flow from investing activities is -$486.00 thousand

    Cash from investing 1-year change

    +69.91%
    TLIS annual cash flow from investing activities is up +69.91% year-on-year

    Cash from financing

    $33.00K
    TLIS annual cash flow from financing activities is $33.00 thousand

    Cash from financing 1-year change

    -91.87%
    TLIS annual cash flow from financing activities is down -91.87% year-on-year

    CAPEX

    CAPEX

    $486.00K
    TLIS annual capital expenditures is $486.00 thousand

    CAPEX 1-year change

    -69.91%
    TLIS annual capital expenditures is down -69.91% year-on-year

    Free Cash Flow

    Free cash flow

    -$53.73M
    TLIS annual free cash flow is -$53.73 million

    Free cash flow 1-year change

    +47.2%
    TLIS annual free cash flow is up +47.2% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -96.84%
    TLIS annual gross profit margin is -96.84%

    Operating margin

    -15.96K%
    TLIS annual operating profit margin is -15.96 thousand%

    Net margin

    -15.05K%
    TLIS annual net profit margin is -15.05 thousand%

    ROA & ROE

    ROA

    -45.08%
    TLIS annual return on assets is -45.08%

    ROE

    -63.32%
    TLIS annual return on equity is -63.32%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TLIS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TLIS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.06
    TLIS price to book ratio is 0.06

    PB ratio Sector rank

    18.29%
    TLIS price to book ratio is higher than 18.29% of companies in Healthcare sector

    PS Ratio

    PS ratio

    9.11
    TLIS price to sales ratio is 9.11

    PS ratio Sector rank

    72.18%
    TLIS price to sales ratio is higher than 72.18% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    -$38.33M
    TLIS enterprise value is -$38.33 million

    Enterprise value Sector rank

    4.09%
    TLIS enterprise value is higher than 4.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.80
    TLIS EV/EBITDA is 0.80

    EV/EBITDA Sector rank

    72.43%
    TLIS EV/EBITDA is higher than 72.43% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    8.86
    TLIS annual current ratio is 8.86

    Quick ratio

    8.86
    TLIS annual quick ratio is 8.86

    Leverage

    Debt to equity

    0.28
    TLIS annual debt to equity ratio is 0.28

    Interest coverage ratio

    -
    TLIS annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    TLIS piotroski f-score value is unknown

    Altman Z-Score

    -9.03
    TLIS altman z-score is -9.03

    Analyst ratings

    Recent major analysts updates

    Aug 16, 23 BTIG
    Sell
    Mar 18, 22 BTIG
    Sell
    Mar 16, 22 B of A Securities
    Underperform
    Jan 7, 22 B of A Securities
    Underperform
    Sep 27, 21 JP Morgan
    Underweight
    Aug 12, 21 Piper Sandler
    Neutral
    Aug 11, 21 JP Morgan
    Neutral
    Mar 9, 21 Piper Sandler
    Overweight
    Mar 9, 21 JP Morgan
    Overweight
    Mar 9, 21 BTIG
    Buy

    Institutional Ownership

    Screeners with TLIS included

    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks recommended to sell
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    Small cap stocks
    • What is the ticker symbol for Talis Biomedical Corporation?
    • Does Talis Biomedical Corporation pay dividends?
    • What sector is Talis Biomedical Corporation in?
    • What industry is Talis Biomedical Corporation in?
    • What country is Talis Biomedical Corporation based in?
    • When did Talis Biomedical Corporation go public?
    • Is Talis Biomedical Corporation in the S&P 500?
    • Is Talis Biomedical Corporation in the NASDAQ 100?
    • Is Talis Biomedical Corporation in the Dow Jones?
    • When was Talis Biomedical Corporation's last earnings report?
    • When does Talis Biomedical Corporation report earnings?

    What is the ticker symbol for Talis Biomedical Corporation?

    The ticker symbol for Talis Biomedical Corporation is NASDAQ:TLIS

    Does Talis Biomedical Corporation pay dividends?

    No, Talis Biomedical Corporation does not pay dividends

    What sector is Talis Biomedical Corporation in?

    Talis Biomedical Corporation is in the Healthcare sector

    What industry is Talis Biomedical Corporation in?

    Talis Biomedical Corporation is in the Medical Devices industry

    What country is Talis Biomedical Corporation based in?

    Talis Biomedical Corporation is headquartered in United States

    When did Talis Biomedical Corporation go public?

    Talis Biomedical Corporation's initial public offering (IPO) was on February 12, 2021

    Is Talis Biomedical Corporation in the S&P 500?

    No, Talis Biomedical Corporation is not included in the S&P 500 index

    Is Talis Biomedical Corporation in the NASDAQ 100?

    No, Talis Biomedical Corporation is not included in the NASDAQ 100 index

    Is Talis Biomedical Corporation in the Dow Jones?

    No, Talis Biomedical Corporation is not included in the Dow Jones index

    When was Talis Biomedical Corporation's last earnings report?

    Talis Biomedical Corporation's most recent earnings report was on January 28, 2025

    When does Talis Biomedical Corporation report earnings?

    The date for Talis Biomedical Corporation's next earnings report has not been announced yet
    On this page